MoonLake Immunotherapeutics Increase (Decrease) in Other Noncurrent Assets
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-10
- MoonLake Immunotherapeutics increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$1.00K.
- MoonLake Immunotherapeutics increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $749.00K, a 55.89% decline year-over-year.
- MoonLake Immunotherapeutics increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $0.00.
- MoonLake Immunotherapeutics increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$1.11M.
- MoonLake Immunotherapeutics increase (decrease) in other noncurrent assets for fiscal 2025 was $587.00K.
- MoonLake Immunotherapeutics increase (decrease) in other noncurrent assets for fiscal 2024 was $0.00.
- MoonLake Immunotherapeutics increase (decrease) in other noncurrent assets for fiscal 2023 was $0.00.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $748.00K 10-Q · filed 2026-08-10 | $748.00K derived: sum of 3 quarters · filed 2026-08-10 | -$362.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $749.00K 10-Q · filed 2026-05-11 | $749.00K derived: sum of 2 quarters · filed 2026-05-11 | -$361.00K derived: sum of 3 quarters · filed 2026-05-11 | -$362.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.11M derived: sum of 2 quarters · filed 2026-02-25 | -$1.11M derived: sum of 3 quarters · filed 2026-08-10 | $587.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | -$1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.11M derived: sum of 2 quarters · filed 2026-08-10 | $587.00K 10-Q · filed 2025-11-05 | $587.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.70M 10-Q · filed 2026-08-10 | $1.70M derived: sum of 3 quarters · filed 2026-08-10 | $1.70M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $1.70M 10-Q · filed 2026-05-11 | $1.70M derived: sum of 2 quarters · filed 2026-05-11 | $1.70M derived: sum of 3 quarters · filed 2026-05-11 | $1.70M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-25 |